MBX Biosciences, Inc. Common Stock (MBX) vs Neogen Corporation (NEOG)

A side-by-side comparison of MBX Biosciences, Inc. Common Stock and Neogen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
MBX Biosciences, Inc. Common Stock logo
MBX
MBX Biosciences, Inc. Common Stock
$2.69B
$56.62HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Neogen Corporation logo
NEOG
Neogen Corporation
$2.65B
$12.14HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT

Total return — MBX vs NEOG

growth of $100 · dividends reinvested · last 2y
MBX +147.5% (+57.3%/yr)NEOG -18.6% (-9.8%/yr)MBX compounded faster over this window
100200300Start $10020252026$248$81
MBX NEOG

MBX vs NEOG: by the numbers

  • •MBX is the larger company ($2.69B vs $2.65B market cap).
  • •Both run net losses; MBX's is the smaller (0.00% vs -0.91% net margin).

Metrics side by side

Valuation

MetricMBXNEOG
Forward P/EN/A39.16
P/S ratioN/A3.04
P/B ratio6.581.26
EV / EBITDAN/A32.47

Profitability

MetricMBXNEOG
Gross margin0.00%46.93%
Operating margin0.00%-2.49%
Net margin0.00%-0.91%
ROE-25.47%-0.38%
ROIC-28.60%-0.68%

Growth (annualized)

MetricMBXNEOG
Revenue CAGR (5Y)N/A13.19%
Total return CAGR (5Y)N/A-21.13%

Go deeper

Full MBX analysisFull NEOG analysisInteractive comparison tool

Dig into the metrics

MBX Biosciences, Inc. Common Stock ROENeogen ROEMBX Biosciences, Inc. Common Stock operating marginNeogen operating marginMBX Biosciences, Inc. Common Stock revenue growthNeogen revenue growthMBX Biosciences, Inc. Common Stock free cash flowNeogen free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.